Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines
Seaport Therapeutics is seeking an Executive Director, Program Leader to drive the GlyphAllo Program in depression treatment, requiring 10+ years biopharmaceutical experience and leadership skills.
Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines
Revolution Medicines